| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A case of MOG encephalomyelitis with T- cell lymphoma
|
Kwon, Young Nam
|
|
|
41 |
C |
p.
|
artikel
|
| 2 |
Alemtuzumab-induced simultaneous onset of autoimmune haemolytic anaemia, alveolar haemorrhage, nephropathy, and stroke: A case report
|
Alnahdi, Muhannad A
|
|
|
41 |
C |
p.
|
artikel
|
| 3 |
Anti-CD20 immunosuppressive disease-modifying therapies and COVID-19
|
Giovannoni, Gavin
|
|
|
41 |
C |
p.
|
artikel
|
| 4 |
Anxiety in Argentinian patients with multiple sclerosis: Prevalence and associated factors
|
Chertcoff, Anibal
|
|
|
41 |
C |
p.
|
artikel
|
| 5 |
Application of the 2017 McDonald criteria for the diagnosis of multiple sclerosis after a first demyelinating event in patients from Argentina
|
Pagani Cassará, Fátima
|
|
|
41 |
C |
p.
|
artikel
|
| 6 |
Aquaporin-4 neuromyelitis optica spectrum disorder in a 2-year-old girl: Diagnostic and treatment considerations
|
Khan, Tuba Rashid
|
|
|
41 |
C |
p.
|
artikel
|
| 7 |
Aseptic meningitis as an atypical manifestation of neuromyelitis optica spectrum disorder flare
|
Shi, Bingxin
|
|
|
41 |
C |
p.
|
artikel
|
| 8 |
CADASIL as Multiple Sclerosis Mimic: A 48-year-old man with severe leukoencephalopathy and spinal cord involvement
|
Motolese, Francesco
|
|
|
41 |
C |
p.
|
artikel
|
| 9 |
Cannabis use in people with multiple sclerosis and spasticity: A cross-sectional analysis
|
Rice, Jessica
|
|
|
41 |
C |
p.
|
artikel
|
| 10 |
Case series: Hearing loss in neuromyelitis optica spectrum disorders
|
Tugizova, Madina
|
|
|
41 |
C |
p.
|
artikel
|
| 11 |
Changing therapeutic strategies and persistence to disease-modifying treatments in a population of multiple sclerosis patients from Veneto region, Italy
|
Marangi, Antonio
|
|
|
41 |
C |
p.
|
artikel
|
| 12 |
Clinical and immunological differences between MOG associated disease and anti AQP4 antibody-positive neuromyelitis optica spectrum disorders: Blood–brain barrier breakdown and peripheral plasmablasts
|
Tanaka, Satoru
|
|
|
41 |
C |
p.
|
artikel
|
| 13 |
Comparison of BICAMS and ARCS for assessment of cognition in multiple sclerosis and predictive value of employment status
|
Maltby, Vicki E.
|
|
|
41 |
C |
p.
|
artikel
|
| 14 |
Comparison of MS inflammatory activity in women using continuous versus cyclic combined oral contraceptives
|
Chen, Chelsea S.
|
|
|
41 |
C |
p.
|
artikel
|
| 15 |
Comparison of the lower limb inter-segmental coordination during walking between healthy controls and people with multiple sclerosis with and without fall history
|
Salehi, Reza
|
|
|
41 |
C |
p.
|
artikel
|
| 16 |
Corrigendum to “Risk factors for reactivation of clinical disease activity in multiple sclerosis after natalizumab cessation” [Multiple Sclerosis and Related Disorders 38 (2020) 101498]
|
Mustonen, Tiina
|
|
|
41 |
C |
p.
|
artikel
|
| 17 |
Corrigendum to “Subcutaneous interferon beta-1a 22/44 µg demonstrates comparable effectiveness versus teriflunomide in newly treated patients with multiple sclerosis. A study in a French nationwide cohort of Multiple Sclerosis: Observatoire Francais de la sclérose en plaques” [Multiple Sclerosis and Related Disorders, 37 (2020) 101598]
|
Rollot, Fabien
|
|
|
41 |
C |
p.
|
artikel
|
| 18 |
Corticospinal inhibition and alexithymia in multiple sclerosis patients–An exploratory study
|
Chalah, Moussa A.
|
|
|
41 |
C |
p.
|
artikel
|
| 19 |
COVID-19 occurring during Natalizumab treatment: a case report in a patient with extended interval dosing approach
|
Borriello, Giovanna
|
|
|
41 |
C |
p.
|
artikel
|
| 20 |
Cross-sectional survey of complementary and alternative medicine used in Oregon and Southwest Washington to treat multiple sclerosis: A 17-Year update
|
Silbermann, Elizabeth
|
|
|
41 |
C |
p.
|
artikel
|
| 21 |
Diagnostic procedures in suspected attacks in patients with neuromyelitis optica spectrum disorders: Results of an international survey
|
D'Souza, Marcus
|
|
|
41 |
C |
p.
|
artikel
|
| 22 |
Differentiate aquaporin-4 antibody negative neuromyelitis optica spectrum disorders from multiple sclerosis by multimodal advanced MRI techniques
|
Zhang, Ningnannan
|
|
|
41 |
C |
p.
|
artikel
|
| 23 |
Dynamic expression of JC virus in urine and its relationship to serostatus
|
Berger, J.R.
|
|
|
41 |
C |
p.
|
artikel
|
| 24 |
Efficacy of robot-assisted gait training in multiple sclerosis: A systematic review and meta-analysis
|
Yeh, Shu-Wei
|
|
|
41 |
C |
p.
|
artikel
|
| 25 |
Empathy in multiple sclerosis––Correlates with cognitive, psychological and occupational functioning
|
van der Hiele, K.
|
|
|
41 |
C |
p.
|
artikel
|
| 26 |
End of dose interval symptoms in patients treated with natalizumab: A role for serum cytokines?
|
Cathérine, Dekeyser
|
|
|
41 |
C |
p.
|
artikel
|
| 27 |
Glioblastoma in a fingolimod-treated multiple sclerosis patient: Causal or coincidental association?
|
London, Frédéric
|
|
|
41 |
C |
p.
|
artikel
|
| 28 |
Identification and functional analysis of specific MS risk miRNAs and their target genes
|
Luo, Deling
|
|
|
41 |
C |
p.
|
artikel
|
| 29 |
Immunosuppression during the COVID-19 pandemic in neuromyelitis optica spectrum disorders patients: A new challenge
|
Carnero Contentti, Edgar
|
|
|
41 |
C |
p.
|
artikel
|
| 30 |
Infections in patients diagnosed with multiple sclerosis: A multi-database study
|
Persson, R.
|
|
|
41 |
C |
p.
|
artikel
|
| 31 |
Is multiple sclerosis a risk factor for infections?
|
Lechner-Scott, Jeannette
|
|
|
41 |
C |
p.
|
artikel
|
| 32 |
Isolated cranial neuritis of the oculomotor nerve: Expanding the MOG phenotype?
|
Kawakami, Saori
|
|
|
41 |
C |
p.
|
artikel
|
| 33 |
Late-onset neutropenia after RITUXIMAB therapy for multiple sclerosis, neuromyelitis optica spectrum disorders and MOG-antibody-associated diseases
|
Rigal, J.
|
|
|
41 |
C |
p.
|
artikel
|
| 34 |
Lichenoid rash: A new side effect of oral Cladribine
|
Aruta, Francesco
|
|
|
41 |
C |
p.
|
artikel
|
| 35 |
Localized sporotrichosis during natalizumab treatment in Multiple Sclerosis
|
Marques, Paula Teixeira
|
|
|
41 |
C |
p.
|
artikel
|
| 36 |
Long-term remission of tumefactive relapsing multiple sclerosis after alemtuzumab rescue treatment in an adolescent patient
|
Baroncini, Damiano
|
|
|
41 |
C |
p.
|
artikel
|
| 37 |
Mitochondrial activity is impaired in lymphocytes of MS patients in correlation with disease severity
|
Armon-Omer, Ayelet
|
|
|
41 |
C |
p.
|
artikel
|
| 38 |
MOG antibody associated demyelinating syndrome presenting as aseptic meningitis in a 6-year-old boy
|
Leinert, Johanna
|
|
|
41 |
C |
p.
|
artikel
|
| 39 |
MRI features associated with rapid disease activity in clinically isolated syndrome patients at high risk for multiple sclerosis
|
De Lury, Amy
|
|
|
41 |
C |
p.
|
artikel
|
| 40 |
Multiple sclerosis prevalence in Santa Fe province, Argentina
|
Luetic, G.
|
|
|
41 |
C |
p.
|
artikel
|
| 41 |
Necrotizing fungal osteomyelitis and fingolimod, 4 years after treatment with fingolimod
|
Harirchian, Mohammad Hossein
|
|
|
41 |
C |
p.
|
artikel
|
| 42 |
Neuropsychiatric and cognitive effects of the COVID-19 outbreak on multiple sclerosis patients
|
Haji Akhoundi, Fahimeh
|
|
|
41 |
C |
p.
|
artikel
|
| 43 |
Non-compliance with disease modifying therapies in patients with Multiple Sclerosis: A qualitative analysis
|
Stratos, Karly
|
|
|
41 |
C |
p.
|
artikel
|
| 44 |
One Aspect of Coronavirus disease (COVID-19) Outbreak in Iran: High Anxiety among MS Patients
|
Naser Moghadasi, Abdorreza
|
|
|
41 |
C |
p.
|
artikel
|
| 45 |
Optic neuritis at disease onset predicts poor visual outcome in neuromyelitis optica spectrum disorders
|
Amaral, Juliana MSS.
|
|
|
41 |
C |
p.
|
artikel
|
| 46 |
Optimization of spectral domain optical coherence tomography and visual evoked potentials to identify unilateral optic neuritis
|
Behbehani, Raed
|
|
|
41 |
C |
p.
|
artikel
|
| 47 |
Phase I randomized trial of liothyronine for remyelination in multiple sclerosis: A dose-ranging study with assessment of reliability of visual outcomes
|
Wooliscroft, Lindsey
|
|
|
41 |
C |
p.
|
artikel
|
| 48 |
Platelet glutamate uptake and Th1 cells inversely correlate in relapsing/remitting and in progressive multiple sclerosis
|
M, Gironi
|
|
|
41 |
C |
p.
|
artikel
|
| 49 |
Predictors of hospitalization in a Canadian MS population: A matched cohort study
|
Al-Sakran, Lina H
|
|
|
41 |
C |
p.
|
artikel
|
| 50 |
Rapid foot-tapping but not hand-tapping ability is different between relapsing-remitting and progressive multiple sclerosis
|
Sato, Sumire
|
|
|
41 |
C |
p.
|
artikel
|
| 51 |
Rebound after discontinuation of teriflunomide in patients with multiple sclerosis: 2 case reports
|
Fuerte-Hortigón, A
|
|
|
41 |
C |
p.
|
artikel
|
| 52 |
Restless legs syndrome among multiple sclerosis patients in Lebanon
|
Makhoul, J.
|
|
|
41 |
C |
p.
|
artikel
|
| 53 |
Seizures and myelin oligodendrocyte glycoprotein (MOG) antibodies: Two paradigmatic cases and a review of the literature
|
Foiadelli, Thomas
|
|
|
41 |
C |
p.
|
artikel
|
| 54 |
Self-remitting cerebral cortical encephalitis associated with myelin oligodendrocyte glycoprotein antibody mimicking acute viral encephalitis: A case report
|
Otani, Tai
|
|
|
41 |
C |
p.
|
artikel
|
| 55 |
Socioeconomic status and disease-modifying therapy prescribing patterns in people with multiple sclerosis
|
Reyes, Saúl
|
|
|
41 |
C |
p.
|
artikel
|
| 56 |
Socioeconomic status and race are correlated with affective symptoms in multiple sclerosis
|
Wang, Yujie
|
|
|
41 |
C |
p.
|
artikel
|
| 57 |
The effect of aquatic physical therapy on patients with multiple sclerosis: A systematic review and meta-analysis
|
Amedoro, Alessio
|
|
|
41 |
C |
p.
|
artikel
|
| 58 |
The epidemiology of comorbidities among multiple sclerosis patients in northeastern Poland
|
Kapica-Topczewska, Katarzyna
|
|
|
41 |
C |
p.
|
artikel
|
| 59 |
The role of cognitive reserve in multiple sclerosis: A cross-sectional study in 526 patients
|
Artemiadis, Artemios
|
|
|
41 |
C |
p.
|
artikel
|
| 60 |
Unraveling a new player in multiple sclerosis pathogenesis: The RNA-binding protein HuR
|
Pistono, Cristiana
|
|
|
41 |
C |
p.
|
artikel
|
| 61 |
Vitamin D and other environmental risk factors in Colombian patients with multiple sclerosis
|
Toro, Jaime
|
|
|
41 |
C |
p.
|
artikel
|
| 62 |
Which is the best PML risk stratification strategy in natalizumab-treated patients affected by multiple sclerosis?
|
Prezioso, Carla
|
|
|
41 |
C |
p.
|
artikel
|
| 63 |
Workplace difficulties, health-related quality of life, and perception of stigma from the perspective of patients with Multiple Sclerosis
|
Maurino, Jorge
|
|
|
41 |
C |
p.
|
artikel
|
Tijdschrift beschrijving